Estromustine
Estromustine (developmental code name Leo 271 f), also known as estrone 17β-3-N-bis(2-chloroethyl)carbamate or estrone–cytostatic complex,[2] is a major active metabolite of the cystotatic antineoplastic agent and estrogen estramustine phosphate, a medication used in the treatment of prostate cancer.[1][3]
Not to be confused with Estramustine phosphate or Estramustine.
Clinical data | |
---|---|
Other names | EoM; Leo 271 f; Estrone 17β-3-N-bis(2-chloroethyl)carbamate; Estrone–cytostatic complex |
Drug class | Chemotherapeutic agent; Estrogen; Estrogen ester |
Pharmacokinetic data | |
Elimination half-life | 14 hours[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C23H29Cl2NO3 |
Molar mass | 438.39 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
References
- Bruce A. Chabner; Dan L. Longo (7 December 2011). Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott Williams & Wilkins. pp. 252–. ISBN 978-1-4511-4820-6.
- http://repository.kulib.kyoto-u.ac.jp/dspace/handle/2433/122855
- Medical Subject Headings: Supplementary chemical records. The Library. 1993. p. 684.
AR |
| ||||||
---|---|---|---|---|---|---|---|
GPRC6A |
| ||||||
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.